Block 3 Flashcards

(38 cards)

1
Q

Define QoL.

A

physical, mental, and social well-being, not just the absence of illness or disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define PRO

A

any endpoint directly from a patient’s perception

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PCORI

A

Patient-Centered Outcomes Research Institute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

4 PRO Domains

A

1) HRQoL
2) Health-State Utility
3) Willingness to Pay
4) Patient Satisfaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

3 health outcomes measures categories

A

1) economic
2) humanistic
3) clinical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

General tool used for measuring general HRQoL?

A

SF-36

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

QALY equation

A

= additional life years * utility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define QALY

A

measure of preference for x time with impaired utility compared to y time with full utility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Define willingness to pay

A

hypothetical measure of preference for items not typically traded in private markets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is contingent valuation?

A

survey methods that asks how much an individual is willing to pay for a good or service

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is conjoint analysis?

A

method of contingent valuation that considers factors other than price

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the goals of medication use?

A

1) alleviate symptoms
2) improve signs
3) cure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What were the 4 components of OBRA?

A

1) assessment of drug use data
2) educational outreach program
3) Prospective DUR
4) Retrospective DUR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

3 pharmacist activities addressed in OBRA 90?

A

1) prospective dur
2) maintenance of patient records/profiles
3) patient counseling standards

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 4 methods in place to prevent med misuse?

A

1) OBRA 90 Standards
2) Patient Counseling Standards
3) MTM
4) MedRec @ transition of care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NCC MERP

A

The National Coordinating Council for Medication Error Reporting and Prevention

17
Q

define medication error

A

any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in control of the healthcare professional, patient, or consumer;

Inappropriate dispensing of a prescribed medication including a variation from the prescriber’s prescription order and failure to identify and manage DTPs

18
Q

ISMP

A

institute for safe medication practices

19
Q

How are root causes of med errors categorized?

A

1) knowledge deficiency
2) performance deficiency
3) system failure

20
Q

5 A’s for responding to med errors.

A

1) acknowledge
2) ask
3) appreciate
4) act to resolve
5) appropriately document

21
Q

how to reduce med errors?

A

C-HOLS

1) good patient history
2) improve order communication (tall man, zeroes, etc)
3) improve label/packaging recognition
4) counsel
4) system enhancements in the pharmacy

22
Q

what is diffusion theory?

A

special type of communication with innovation & communication over time

an idea is perceived as new by an individual “innovation”
and participants create and share information
over time

23
Q

What are the 2 major determinants of prescribing behavior?

A

1) practice characteristics

2) physician demographics

24
Q

What components of practice characteristics may influence prescribing behavior?

A

1) location
- - rural, is monitoring difficult, detailing visits
2) nature of practice
- - solo/group, IT, types of patients, detailing policies
3) practice size
- - more patients, more opportunities for new drug
- - more prescribers, faster diffusion

25
How do physician demographics affect prescribing behavior?
less likely to adopt new drug with... - - increasing age - - female gender
26
How do manufacturers market their products?
historically, physicians & prescribers; but now, also DTC 1) DTC <15% of marketing costs 2) prescriber: 80% of marketing costs
27
What are potential interventions to influence prescribing behavior?
RACCE prescribing 1) reminders 2) audit & feedback 3) clinical practice guidelines 4) computerized decision support systems 4) educational outreach/academic detailing
28
What is the Alosa Foundation?
Part of the independent drug information service at harvard medical school.
29
Define interdisciplinary healthcare team.
a group of individuals with diverse training and backgrounds who work together as an identified unit or system
30
What are the specific components of a collaborative practice?
G-MAP 1) common goals 2) mechanisms for communication/monitoring 3) appropriate contributions 4) common patients
31
What are facilitating values in a collaborative practice?
1) knowledge --> trust 2) shared responsibility 3) mutual respect 4) communication 5) coordination & cooperation 6) optimism
32
What is the most effective delivery method of successful quality care?
optimism
33
What is necessary for the development of trust?
knowledge
34
What is the goal of academic detailing?
to close the gap between best evidence and actual prescribing to maximize efficacy, safety, and cost-effectiveness
35
What does SBAR stand for?
Situation, Background, Assessment, Recommendation
36
What are the important aspects for improving communication skills?
NVR LIE 1) non-verbal communication 2) verbal communication 3) build rapport 4) listen actively 5) involve the patient 6) empathetic
37
What is empathy?
the ability to see the world through another's eyes
38
What are general categories for barriers to effective communication?
1) environmental 2) pharmacist 3) patient 4) financial/admin 5) time